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View Online / Journal Homepage / Table of Contents for this issueOn-line liquid chromatography neutral loss-triggered electron transfer
dissociation mass spectrometry for the targeted analysis of citrullinated
peptides†
Andrew J. Creese,ab Melissa M. Grant,a Iain L. C. Chapplea and Helen J. Cooper*b
Received 29th June 2010, Accepted 5th November 2010
DOI: 10.1039/c0ay00414fCitrullination is a post-translational modification of proteins which deiminates arginine, increasing the
mass by 0.98 Da. Protein citrullination is a known biomarker for multiple sclerosis and a potential
biomarker for rheumatoid arthritis. Collision-induced dissociation (CID) tandem mass spectrometry of
citrullinated peptides produces a dominant neutral loss of isocyanic acid (HNCO, 43 Da) from the
deiminated arginine amino acid side-chain. Here we show that the loss of isocyanic acid in CID can be
used as a trigger for targeted analysis by supplemental activation electron transfer dissociation
(saETD). Unlike CID, post-translational modifications (PTMs) are retained on peptide backbone
fragments produced by saETD, improving the confidence in assignment of both peptide sequence and
PTM site. The method is demonstrated for four synthetic peptides spiked into complex trypsin-digested
saliva samples and a commercial six protein tryptic mixture. In contrast to CID alone, the neutral-loss
triggered ETD approach results in high confidence identification of three of the four peptides, including
an unexpected disulfide-bound dimer, and zero false positives.Introduction
Citrullination is a post-translational modification (PTM) of
proteins in which an arginine amino acid residue is converted to
citrulline via deimination, see Scheme 1. The modification has the
same mass increase (+0.9840 Da) as deamidation of asparagine
or glutamine residues.1 The citrullination of arginine is caused by
a group of calcium dependent enzymes called peptidylarginine
deiminases (PADs).2 The conversion of arginine to citrulline
decreases the isoelectric point (pI) of the protein and affects its
structure and function. Increased levels of citrullinated myelin
basic protein have been detected in the brains of patients
suffering from multiple sclerosis3,4 and Alzheimer’s disease.5
Citrulline-modified proteins vimentin, fibronectin and a-enolase
have also been detected as part of the inflammatory-immune
response in rheumatoid arthritis (RA).6–8 The modification ofScheme 1 The conversion of the amino acid residue arginine (left) to
citrulline (right).
aSchool of Dentistry, Periodontal Research Group, University of
Birmingham, St Chads Queensway, Birmingham, B4 6NN, UK
bSchool of Biosciences, University of Birmingham, Birmingham, B15 2TT,
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† Electronic supplementary information (ESI) available: The m/z values
and ion intensities for all informative fragments from MS/MS spectra
in figure 1 are shown in table S1. See DOI: 10.1039/c0ay00414f
This journal is ª The Royal Society of Chemistry 2011these proteins is used as a serum biomarker for RA.6 In addition
to those described above, the histones9,10 H3, H2A and H4 and
myosin11 have been shown to be citrullinated. The apparent
specificity of citrullination increases its potential as a disease
biomarker.
A significant association has been demonstrated between
periodontitis and rheumatoid arthritis in epidemiological
research,12 but specific mechanistic links between these two
chronic inflammatory diseases have not been fully elucidated.12
One of the principal pathogenic bacteria in periodontitis, Por-
phyromonas gingivalis,13 is thought to also play a role in RA.14
P. gingivalis is the only known periodontal bacterium to contain
a PAD enzyme15 and this organism is found in both the gingival
crevicular fluid (GCF)16 and saliva17 of patients with perio-
dontitis. Saliva may therefore be a suitable and convenient
substrate for the non-invasive diagnosis of RA.
Tandem mass spectrometry-based proteomics methods are
routinely used to identify the peptides and proteins present in
a biological sample18–20 and to characterise any post-trans-
lational modifications.21,22 A standard proteomics approach is to
digest a protein mixture with trypsin and use on-line reversed-
phase liquid chromatography (LC) to separate the peptides.23,24
The LC is coupled to collision induced dissociation (CID)25
tandem mass spectrometry (MS/MS). CID fragments peptide
ions by cleaving the N–C0 bond producing b and y
26 fragment
ions, thus providing sequence information which can be searched
against protein databases. Algorithms are employed to match the
measured peptide mass spectrum with those calculated from in
silico digests of proteins contained in a database. The peptide
assignment is scored according to the similarity between the
experimental data and the theoretical mass spectrum. Using this
approach, it is possible to identify thousands of peptides (and
proteins) from an LC-MS/MS analysis.27 CID fragmentation is
a thermal process: one of the drawbacks of CID is theAnal. Methods, 2011, 3, 259–266 | 259
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View Onlinepreferential loss of post-translational modifications at the
expense of sequence fragments. This occurrence can hinder both
peptide identification and localisation of the site of the modifi-
cation. Electron transfer dissociation (ETD) is a tandem mass
spectrometry technique, analogous to electron capture dissocia-
tion (ECD),28 developed by Syka et al. in 2004.29 Both ETD and
ECD involve radical ion chemistry and result in the cleavage of
the N–Ca peptide bond, producing c and zc ions. There are
significant advantages gained by fragmentation of peptides with
ETD or ECD: fragmentation is random and relatively non-
selective, the only exception being cleavage N-terminal to
proline,30 hence the extent of peptide sequence coverage is often
greater than for CID.31,32 Furthermore, in ET/CD, labile post-
translational modifications (PTMs) are retained on the peptide
backbone fragments. The site of modification can therefore be
localised: g-carboxyglutamic acid,33 phosphorylation (S, T and
Y),34–37 N and O glycosylation,38–40 acylation,41 sulfation,33
methionine oxidation,42 sumoylation43 and ubiquitination44 have
all been successfully localised. One drawback of ETD is that non-
covalent bonds are not necessarily cleaved. Despite N–Ca bond
cleavage, the fragments may not separate due to inter-fragment
non-covalent interactions. The situation is exacerbated for
doubly charged precursor peptide ions: electron transfer reduces
the charge by one and there is no Coulombic repulsion to aid
separation of the fragments. In order to address that challenge,
Swaney et al.45 developed supplemental activation ETD (saETD)
in which the charge-reduced ion is collisionally activated, thus
disrupting any non-covalent bonding.
Tandem mass spectrometry has previously been applied to the
localisation of sites of citrullination on synthetic peptides46,47 and
the protein nucleophosmin47 (known to be citrullinated). Hao
et al.47 fragmented the synthetic citrullinated peptides (AAX-
AA,AKXHXKVLXDNIC) and the citrullinated nucleophosmin
peptide (SIXDTPAK) using CID (where X is a citrulline
residue). Fragmentation produced a dominant peak corre-
sponding to the neutral loss of isocyanic acid (43 Da, HNCO)
from the citrulline side-chain, see Scheme 2. In addition, CID of
citrullinated peptides produces fragment ion series correspond-
ing to b (43 Da) and y (43 Da) ions. Hao et al. used the
neutral loss and ion series to distinguish citrullination from
deamidation which does not produce a neutral loss. That
approach detects the presence of citrullination. To localise the
site of citrullination in peptides with more than one arginine (it
has been suggested that the presence of citrullination abrogates
the site of trypsin cleavage48), a full ion series (all b and y ions of
43 Da) would be required. This process is also reliant on all
citrullinated peptides producing the 43 Da ion series. In
a separate approach, citrullinated residues were modified using
2,3-butanedione and anti-pyridine,46 a tagging process used toScheme 2 Collision induced dissociation of citrulline.
260 | Anal. Methods, 2011, 3, 259–266detect citrullination in antibody staining,49 resulting in a mass
increase of 239.1 Da. On CID, a dominant peak with an m/z
value of 201.1 corresponding to loss of the tag is observed
whereas ETD of the modified peptides did not result in any
neutral losses. By performing (non-targeted) alternating CID
and ETD analyses, peptides with the modification were identified
by observation of the neutral loss following CID and the site of
citrullination was localised from the ETD mass spectrum. Using
this technique citrullination sites were identified on myelin basic
protein (MBP). This method is time-consuming in terms of
sample preparation. In addition, the requirement for CID and
ETD analysis of each peptide increases the duty cycle time thus
decreasing the number of MS/MS events and increasing the
likelihood of false negatives.
Previous work in our laboratory has shown that observation
of a neutral loss of phosphoric acid (H3PO4, 98 Da) from
a phosphopeptide following CID can be used as a trigger for
subsequent ECD of the phosphopeptide parent ion.50 Here, we
use the neutral loss of isocyanic acid (HNCO, 43 Da) observed in
CID of citrullinated peptides to trigger saETD of the parent ion.
Citrullinated peptides were synthesised and spiked into tryptic
digests of saliva thus simulating the type of media in which cit-
rullinated proteins may be present. The mixture was separated by
reversed-phase liquid chromatography coupled to an LTQ
Orbitrap Velos ETD mass spectrometer. As the peptides eluted,
CID was performed. If a peak corresponding to the loss of iso-
cyanic acid was observed in the CID mass spectrum, saETD of
the precursor peptide ion was performed (i.e., this approach does
not involve MS3 of the neutral loss ions). The MS/MS data were
searched against a protein database using the SEQUEST51
algorithm. The algorithm matches the MS/MS spectrum to
a spectrum of a theoretical peptide from the protein database.
The results show that the four synthetic citrullinated peptides can
be manually identified by both CID and saETD. The filtered
database search results of the saETD data identified three of the
four peptides with high confidence. However, the database
search of the CID data only identified two of the synthetic
peptides and falsely identified several non-citrullinated peptides.
On manual analysis these incorrect identifications proved to be
either deamidated peptides or incorrectly assigned mass spectra
(false positives). There were several mechanical false positives,
i.e., instances in which CID triggered saETD in the absence of
a citrullinated peptide, however, database searching of the
saETD data did not identify these as additional citrullinated
peptides, i.e., saETD resulted in zero false positives.Results and discussion
Saliva analysis
Three synthetic peptides (ILNXTSFAK, VVEXHQSACK and
LYNLHGDXSYVLSK; X is a citrulline residue) were spiked
into a trypsin digest of saliva. The sample was loaded onto
a reversed phase C18 column and separated over a 30 minute
gradient. The eluting peptides were fragmented by collision
induced dissociation (CID). If one of the three most abundant
peaks corresponded to the loss of 43 Da from the precursor ion,
the precursor ion was subjected to supplemental activation
electron transfer dissociation (saETD). The data were analysedThis journal is ª The Royal Society of Chemistry 2011
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View Onlineusing the SEQUEST algorithm and searched against the human
IPI database (v3.66) supplemented with the sequences of the
synthetic peptides. The results were filtered by XCorr (a measure
of how close an experimental MS/MS spectrum is to the theo-
retical MS/MS spectrum) vs. charge state. XCorr values less than
2, 2.25 and 2.5 were rejected for charge states 2+, 3+ and 4+
respectively. In the analysis of the saliva sample, all three
synthetic peptides could be manually identified from the CID and
saETD spectra. In the filtered database search two of the three
peptides were identified from the saETD spectra, however, none
of the peptides were identified by CID. A total of 1344 MS/MS
events were triggered during the LC-MS/MS gradient. Of these,
1280 were CID events. The database search of the CID data
identified 76 human proteins. saETD was triggered for 64
precursor ions. Thirteen of the saETD events corresponded to the
three synthetic peptides in doubly and/or triply charged states.
Two of the saETD events corresponded to unexpected disulfide-
bound dimers of one of the peptides. The SEQUEST search of
the saETD data identified two additional peptides neither of
which were citrullinated (KGDTFSCMVGHEALPLAFTQK
and LGHPDTLNQGEFK). The remaining 47 saETD spectra
did not result in positive peptide identifications following the
database search. These saETD events were mechanical false
positives; that they were not identified in the database search as
citrullinated peptides highlights the robustness of the method.
The shortest synthetic peptide (peptide 1: ILNXTSFAK) was
observed as a doubly charged ion (m/z 525.802) only. Fig. 1A
shows a survey MS spectrum (top), with subsequent CID
(middle) and saETD (bottom) mass spectra. The most abundant
peak in the CID mass spectrum corresponds to the neutral loss of
43 Da (Dm/z 21.37 for 2+ peptide), i.e., isocyanic acid, HNCO.
CID was performed thirteen times on the doubly charged ion of
peptide 1. Of these thirteen events, nine triggered saETD. The
CID mass spectrum shown gave the highest XCorr but is of poor
quality with very few peaks above baseline noise. Nevertheless,
the database search and manual analysis of the mass spectrum
revealed that all eight N–C0 bonds are cleaved. All eight N–Ca
bonds are cleaved by saETD to produce abundant fragments, as
confirmed by both the SEQUEST search and manual analysis of
the mass spectrum. The SEQUEST XCorr score for both the
CID mass spectrum and the saETD mass spectrum was 1.7. The
disparity in search scores as related to spectral appearance is in
part because the search algorithm is designed for CID data,
rather than EC/TD data, and does not take into account some of
the differences in the fundamental chemistry of the two tech-
niques.52,53
The second synthetic peptide (peptide 2: VVEXHQSACK)
was only observed as a triply charged ion (m/z 386.530). CID was
performed once and saETD was triggered. Fig. 1B shows the
survey MS spectrum (top), CID mass spectrum (middle) and the
saETD mass spectrum (bottom). The peak corresponding to
a neutral loss of 43 Da (Dm/z 14.03) was the third most abundant
fragment ion in the CID mass spectrum. The CID mass spectrum
was not of sufficient quality to identify the peptide via the
database search. However, manual analysis revealed that five N–
C0 bonds were cleaved. The peptide was identified by the data-
base search of the saETD data with an XCorr of 2.82. Manual
analysis of the saETD mass spectrum, and the database search,
revealed all nine N–Ca backbone bonds were cleaved.This journal is ª The Royal Society of Chemistry 2011An unexpected peak corresponding to quadruply charged ions
of a disulfide-bound dimer of peptide 2 (m/zcalc 578.786, m/zmeas
578.787, D 1.0 ppm) was observed (Fig. 1C). CID was performed
once and saETD was triggered. Manual analysis of the CID mass
spectrum (Fig. 1C, middle) showed that there were no fragments
unique to the monomer or the dimer of the peptide. However,
there was a peak corresponding to a neutral loss of 43 Da, i.e.
([2M + 4H]–HNCO)4+, hence the saETD event. Manual
inspection of the saETD mass spectrum (Fig. 1C, bottom)
showed that seven out of nine N–Ca bonds were cleaved. No
fragments were observed which contained the intact disulfide
bond. Identification of this unexpected citrullinated species
demonstrates the power of the neutral-loss triggered saETD
approach. A peak corresponding to the triply charged dimer (m/z
771.382) was also observed. CID was performed and a neutral
loss (Dm/z 14) triggered saETD. On manual inspection of both
the CID and saETD spectra, no fragment ions were observed.
Dimer ions in the 5+ and 6+ charge states (m/z 463.231, m/z
386.194 respectively) were also observed. CID was only per-
formed on the 5+ charge state, however, as the neutral loss from
a 5+ ion (Dm/z 8.6) was not included in the method, saETD was
not triggered. Manual analysis of the CID mass spectrum failed
to identify any backbone fragments. Peptide 2 had previously
been analysed by direct infusion (DI) electrospray and no dimers
were observed. That suggests that the dimer bond may be formed
during the elution on the HPLC column or could be the result of
different solvent conditions (for DI, peptides are resuspended in
methanol : water, 70 : 30 + 1% formic acid).
Fig. 1D shows neutral loss triggered saETD for the doubly
charged ion (m/z 833.434) of the third synthetic peptide (peptide
3: LYNLHGDXSYVLSK) (survey mass spectrum (top), CID
mass spectrum (middle), saETD mass spectrum (bottom)). CID
was performed once. The most abundant peak in the
CID spectrum corresponds to the loss of 43 Da from the
precursor ion and hence saETD was triggered. Twelve of the
thirteen N–C0 bonds were cleaved by CID as identified by both
manual analysis and the SEQUEST search. The CID XCorr
score for the peptide was 1.54. All N–Ca bonds were cleaved by
saETD as identified by both manual analysis and the SEQUEST
search. The XCorr score for the saETD spectrum was 2.8. The
triply charged ion for peptide 3 (m/z 555.959) was analysed by
CID three times triggering saETD twice. The highest-scoring
CID spectrum (Fig. 1E, middle) of this ion shows a neutral loss
of 43 (Dm/z 14.14). Manual analysis revealed that nine of the
thirteen N–C0 bonds were cleaved, however, the SEQUEST
search of these spectra gave an XCorr of 1.1, a value which does
not pass the filters. In the saETD mass spectrum all thirteen N–
Ca bonds were cleaved (observed in both the SEQUEST search
and manual analysis) (Fig. 1E, bottom) and the database search
resulted in an XCorr score of 4.56.
The data from the synthetic peptides spiked into a tryptic
saliva digest show that in all cases the synthetic peptides are
identified from unfiltered database searches of the saETD mass
spectra with the same, or greater, XCorr score obtained from
searching the CID data. The filtered database search results show
CID does not identify any of the peptides whereas saETD
identifies two of the three peptides. CID of peptide 2
(VVEXHQSACK) produced a neutral loss (thus triggering
saETD) but insufficient backbone fragments for identification inAnal. Methods, 2011, 3, 259–266 | 261
Fig. 1 Neutral-loss triggered saETD of the four citrullinated peptides. Survey MS scan (top), CID MS/MS scan (middle) and saETD MS/MS scan
(bottom) for: doubly charged peptide [ILNXTSFAK + 2H]2+ ions (A); triply charged peptide [VVEXHQSACK + 3H]3+ ions (B); quadruply charged
dimer ions of the peptide VVEXHQSACK (C); doubly charged peptide [LYNLHGDXSYVLSK + 2H]2+ ions (D); triply charged peptide
[LYNLHGDXSYVLSK + 3H]3+ ions (E); and triply charged peptide [IHAXEEIFDSXGNPTVEVDLFTSK]3+ ions (F). X is citrulline. Inset: sequence
coverage obtained. cR is citrulline. The m/z values and ion intensities for the informative fragments are shown in Table S1, ESI†.
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View Onlinethe database search. There were no false negatives in the data-
base search of the saETD spectra (saETD was triggered 64
times). Two of the additional saETD events were matched to real
peptides (KGDTFSCMVGHEALPLAFTQK and
LGHPDTLNQGEFK), neither of which were citrullinated or
deamidated. In both of these cases, the parent ions were triply
charged. The saETD was triggered by peaks Dm/z 21.15 less than262 | Anal. Methods, 2011, 3, 259–266the precursor (corresponding to the neutral loss from a 2+ cit-
rullinated ion) for peptide KGDTFSCMVGHEALPLAFTQK
and Dm/z 11.15 (corresponding to the neutral loss from a 4+
citrullinated ion) for peptide LGHPDTLNQGEFK. The filtered
database search of the CID data ‘identified’ ten additional
peptides as containing citrullinated arginine residues (false
positives). Manual analysis of the mass spectra of those speciesThis journal is ª The Royal Society of Chemistry 2011
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View Onlineconfirms them as either incorrectly assigned spectra (incorrect
sequence, 3) or as having the correct sequence but containing
either deamidated asparagine or glutamine residues rather than
citrulline (7).
In order to test the suitability of the NL-saETD approach for
longer and multiply citrullinated peptides, an additional peptide
(IHAXEEIFDSXGNPTVEVDLFTSK; X are citrulline resi-
dues) was synthesized. The peptide was spiked into a separate
saliva digest, analysed and the data searched against the database
as described above. The peptide was observed as triply charged
ions and the NL-saETD is shown in Fig. 1F (survey mass spec-
trum (top), CID mass spectrum (middle), saETD mass spectrum
(bottom)). CID was performed twice. On both occasions saETD
was triggered. The CID spectrum (Fig. 1F, middle) shows a peak
corresponding to a neutral loss of 43 Da (Dm/z 14.07), i.e. loss of
HNCO. There are no peaks corresponding to loss of two HNCO
molecules. Manual analysis of the CID mass spectrum revealed
19 of the 23 N–C0 bonds were cleaved. Those cleavages were also
identified in the SEQUEST search and the XCorr value was 2.63.
Manual analysis of the saETD spectrum (Fig. 1F, bottom)
showed 22 of the 23 N–Ca bonds were cleaved. (The missed
cleavage was N-terminal to proline. Such cleavages are rarely
observed following ETD or ECD due to the cyclic nature of the
amino acid side-chain.30) The database search of the saETD data
resulted in an XCorr of 4.8. Two additional saETD events were
matched to non-citrullinated peptides (KAQMQTDDR and
KGDTFSCMVGHEALPLAFTQK) in the SEQUEST search.
Twelve additional peptides were incorrectly identified as cit-
rullinated in the filtered SEQUEST search of the CID data.
Manual inspection revealed that 8 of these were in fact deami-
dated rather than citrullinated and the remaining four were
identified as incorrectly assigned, i.e., incorrect sequence.Six protein mix analysis
Analysis of the six protein mix containing the three singly cit-
rullinated peptides gave similar results to those obtained for the
saliva digest. A trypsin-digested six protein mix was purchased
from LC Packings (Sunnyvale, USA). The three synthetic
peptides were spiked into the digest. The sample was analysed as
above. The concentrations loaded were 50 femtomoles of the six
protein digest and 25 femtomoles of the synthetic peptides.
Collision induced dissociation was performed 721 times and
saETD was triggered 56 times during the LC-MS/MS run. Ten of
the saETD mass spectra can be assigned to the synthetic peptides
and the unexpected disulfide-bound dimer. Of the additional 46
saETD spectra, two spectra resulted in positive identification in
the SEQUEST search (LKECCDKPLLER and YSQQQL-
METSHR), neither of which were citrullinated. All three
peptides were identified by saETD, i.e., there were no false
negatives, however, only one of the peptides was assigned in the
filtered database search of the CID data (ILNXTSFAK). saETD
resulted in no false positives whereas CID resulted in 3 false
positives.
Peptide 1 was observed as a doubly charged ion (m/z 525.802).
CID was performed 8 times. Four of these CID events triggered
saETD. For the CID and saETD spectra, both the SEQUEST
search and manual analysis identified cleavage of all eight
backbone bonds. The SEQUEST XCorr for the CID spectrumThis journal is ª The Royal Society of Chemistry 2011was 2.06 compared to 1.64 for the saETD spectrum. Peptide 2
was observed as a triply charged ion (m/z 386.530). CID was
performed twice; saETD was triggered twice. Manual analysis
and the SEQUEST search of the saETD mass spectrum showed
all N–Ca bonds were cleaved and the database search gave an
XCorr score of 2.89. In CID, only five of the nine peptide bonds
were cleaved, resulting in an XCorr score of 0.67 which is below
the filter cut-off. The quadruply charged disulfide-bonded dimer
of peptide 2 was detected and the neutral loss of 43 Da in CID
triggered saETD. Manual analysis of the CID spectrum did not
identify any unique fragment ions. Peptide 3 was present as
doubly (m/z 833.435) and triply charged ions (m/z 555.959);
saETD was triggered for both ions (once for the doubly charged
ion and twice for the triply charged ion). The saETD mass
spectrum of the triply charged ion showed cleavage of twelve of
the thirteen N–Ca bonds (identified in both the SEQUEST
search and manually) with an XCorr score of 4.57. Manual
analysis of the CID mass spectrum showed nine of the thirteen
bonds cleaved but did not result in a positive identification in the
filtered dataset. Removing the filters showed the XCorr value to
be 0.91. The CID spectrum of the doubly charged ion showed ten
of the thirteen N–C0 bonds were cleaved (identified in the
SEQUEST search and manually) resulting in an XCorr of 1.6,
again below the filter threshold. The dominant peak corre-
sponded to the neutral loss of 43 Da. However, the resulting
saETD spectrum was of very low quality. There were no frag-
ments identified and therefore no XCorr was reported.
Two saETD events resulted in positive non-citrullinated
peptide identifications in the SEQUEST search
(LKECCDKPLLER and YSQQQLMETSHR), i.e., although
saETD was triggered, the database search did not incorrectly
identify the peptides as citrullinated, again demonstrating the
robustness of the approach. Three additional peptides were
incorrectly identified as citrullinated from the CID data. Manual
analysis of these spectra showed that in all cases the peptide was
deamidated rather than citrullinated (false positives).
In a separate analysis the fourth citrullinated peptide
(IHAXEEIFDSXGNPTVEVDLFTSK) was spiked into the six
protein digest mix and analysed as described above. As previ-
ously, peptide 4 was detected as triply charged ions (m/z 921.461).
CID was performed three times. On each occasion saETD was
triggered. The CID mass spectrum revealed cleavage of 19 of the
23 N–C0 bonds (identified both manually and in the SEQUEST
search). The saETD mass spectrum also showed 19 of the 23 N–
Ca bonds were cleaved. The XCorr scores for CID and saETD
were 4.87 and 4.91 respectively. As above, two additional saETD
spectra were identified in the SEQUEST search as non-citrulli-
nated peptides (LKECCDKPLLER and NYELLCGDNTRK).
Two additional peptides were incorrectly identified as citrulli-
nated in the SEQUEST search of the CID data. Manual analysis
showed that both were in fact deamidated peptides.
Table 1 summarises the XCorr scores for the MS/MS events
from which the four synthetic peptides were identified in both the
saliva and six protein digests. The table shows that in all cases,
saETD of triply charged peptide ion results in a higher score than
CID. This is to be expected: Swaney et al.54 have shown that the
database search scores of saETD mass spectra of triply charged
ions up to m/z z 700 are higher than the scores from corre-
sponding CID mass spectra. saETD of the doubly chargedAnal. Methods, 2011, 3, 259–266 | 263
Table 1 SEQUEST XCorr values for the CID and saETD mass spectra
of the four citrullinated peptides in all observed charge states. Values in
brackets are below the filter cut-off
XCorr score
CID saETD
Peptides spiked into saliva
[ILNXTSFAK]2+ (1.7) (1.7)
[VVEXHQSACK]3+ — 2.82
[LYNLHGDXSYVLSK]2+ (1.54) 2.8
[LYNLHGDXSYVLSK]3+ (1.1) 4.56
[IHAXEEIFDSXGNPTVEVDLFTSK]3+ 2.63 4.8
Peptides spiked into six protein mix
[ILNXTSFAK]2+ 2.06 (1.64)
[VVEXHQSACK]3+ (0.67) 2.89
[LYNLHGDXSYVLSK]2+ (1.6) —
[LYNLHGDXSYVLSK]3+ (0.91) 4.57
[IHAXEEIFDSXGNPTVEVDLFTSK]3+ 4.87 4.91
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View Onlinepeptides identified in the saliva digest gave equal or higher Xcorr
scores than the corresponding CID data. saETD of the doubly
charged ions in the six protein digestion results gave lower scores
than the CID data.
Table 2 summarises the total number of CID and saETD
events which were performed for the four experiments. The saliva
digests were more complex mixtures and therefore more MS/MS
events would be expected when compared to the six protein mix.
In the first saliva analysis, the total number of events resulting in
positive identifications of the synthetic citrullinated peptides
from the filtered SEQUEST search was zero and eight for CID
and saETD respectively. In the second saliva analysis, the fourth
citrullinated peptide was identified twice by both CID and
saETD. For the six protein mix spiked with peptides 1–3, one
CID and four saETD events resulted in positive identification of
the citrullinated peptides and for the six protein mix spiked with
peptide 4, three CID and three saETD events resulted in positive
identification. Ten CID events resulted in erroneous identifica-
tion of citrullinated peptides in the saliva analysis spiked withTable 2 The total number of CID and saETD events performed. The total n
citrullinated peptides and the false positive rates for citrullination identificati
MS/MS events
# Events resulting in
positive ID of synthetic
peptides
Saliva spiked with synthetic peptides 1–3
CID 1280 0
saETD 64 8
Saliva spiked with synthetic peptide 4
CID 1651 2
saETD 66 2
MS/MS events
# Events resulting in
positive ID of synthetic
peptides
Six protein mix spiked with synthetic peptides 1–3
CID 721 1
saETD 56 4
Six protein mix spiked with synthetic peptide 4
CID 1047 3
saETD 93 3
264 | Anal. Methods, 2011, 3, 259–266peptides 1–3 and twelve CID events in the saliva analysis spiked
with peptide 4, giving false positive rates of 0.8% and 1.1%
respectively. Three CID events in the six protein analysis spiked
with peptides 1–3 and two CID events in the analysis spiked with
peptide 4 resulted in incorrect identifications of citrullinated
peptides. The false positive rates for the six protein mix analyses
were 0.4% and 0.2%. The SEQUEST search of the saliva digest
spiked with peptides 1–3 shows that none of the CID spectra for
the synthetic peptides were of sufficient quality to identify the
peptides in a filtered database search. Twenty out of the 27
incorrectly assigned peptides were deamidated. There were no
false positives identified from the saETD data from either the
saliva or six protein mix experiments.
Experimental
Materials
The six protein tryptic mix was purchased from LC Packings
(Sunnyvale, USA) and used without further purification. Four
citrullinated peptides were synthesised by Alta Biosciences (Bir-
mingham, UK). Saliva was collected for three minutes into a 15
mL Falcon tube from BD Biosciences (CA, USA). Dithio-
threitol, iodoacetamide and formic acid were purchased from
Fisher Scientific (UK). Trypsin gold was purchased from
Promega (USA). HPLC grade water and acetonitrile were
purchased from Baker (Holland).
Sample preparation
Preparation of synthetic peptides. The three synthetic peptides
(ILNXTSFAK, VVEXHQSACK and LYNLHGDXSYVLSK;
X is a citrulline residue) were each re-suspended in water to
a concentration of 1 pmol mL1. The synthetic peptide (IHAX-
EEIFDSXGNPTVEVDLFTSK, X are citrulline residues) was
re-suspended in methanol to a concentration of 1 pmol mL1.
Preparation of saliva digest. The saliva sample was centrifuged
at 12 000 rpm for 10 minutes. The supernatant was retained. Anyumber of CID and saETD spectra resulting in positive identifications of
on
# Events resulting in ID of
additional citrullinated peptides
(false positives) False positive rate (%)
10 0.8
0 0
12 1.1
0 0
# Events resulting in ID of
additional citrullinated peptides
(false positives) False positive rate (%)
3 0.4
0 0
2 0.2
0 0
This journal is ª The Royal Society of Chemistry 2011
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View Onlinedisulfide bonds in the saliva sample (100 mL) were reduced with
dithiothreitol and alkylated by use of iodoacetamide. The sample
was digested with trypsin at 37 C overnight. The digested sample
was desalted with a Michrom macro trap (CA, USA). The
trap was wetted using acetonitrile : water (50 : 50, 300 mL)
(Baker, Holland) and washed with trifluoroacetic acid (0.1%, 200
mL) (Fisher, UK). The sample was loaded onto the trap and
washed with trifluoroacetic acid (0.1%, 200 mL) and eluted in
acetonitrile : water (70 : 30, 200 mL). The sample was vacuum
centrifuged dry and resuspended in formic acid (100 mL, 0.1%).
The samples were further diluted (25 times dilution giving
approximately 40 ng mL1 of proteins) prior to analysis. The
three synthetic singly citrullinated peptides were spiked into the
sample to give a final concentration of 5 fmol mL1. 5 mL of
sample was loaded into the HPLC system (200 ng of protein
digest and 25 femtomoles of each synthetic peptide). The doubly
citrullinated peptide was spiked into a separate saliva sample to
give a final concentration of 20 fmol mL1. 5 mL of sample was
loaded into the HPLC system (200 ng of protein digest and 100
femtomoles of the synthetic peptide).
Preparation of six protein mix. The six protein tryptic digest
mix (lysozyme, cytochrome c, yeast alcohol dehydrogenase,
bovine serum albumin, apo-transferrin and b-galactosidase) was
re-suspended and diluted in formic acid (0.1%) (Fisher Scientific,
UK) to give a final concentration of 10 fmol mL1. The three
synthetic singly citrullinated peptides were spiked into the sample
to give a final concentration of 5 fmol mL1 of each peptide. The
six protein mix as supplied has been treated with iodoacetic acid
to carboxymethylate cysteine residues. The doubly citrullinated
peptide was added to a separate sample of six protein digest mix
to give a final loading of 100 fmol.Instruments and experimental conditions
LC-CID-saETD-MS/MS. On-line liquid chromatography was
performed by use of a Dionex Ultimate 3000 HPLC system
(Sunnyvale, USA). The samples were loaded onto a 75 mm
(internal diameter) Acclaim PepMap100 (LC Packings, Sunny-
vale, USA) C18 column (length 10 cm) and separated over a 30
minute gradient from 3.2% to 44% acetonitrile (0.1% formic
acid). Peptides were infused by use of an Advion Triversa
Nanomate (Ithaca, USA) electrospray ionization source directly
into a Thermo Scientific LTQ-Orbitrap Velos ETD mass spec-
trometer (Bremen, Germany), at a flow rate of 350 nL min1.
The mass spectrometer alternated between a full FT-MS scan
(m/z 380–1600) and subsequent MS/MS scan(s) of the most
abundant precursor ions. Survey scans were acquired in the
Orbitrap with a resolution of 60 000 at m/z 400. Precursor ions
were isolated and subjected to CID in the linear ion trap.
Isolation width was 2 Th. Automatic gain control (AGC) was
used to accumulate sufficient precursor ions (target value 1  105
charges, maximum fill time 25 ms). CID was performed with
helium gas at a normalised collision energy of 35%. Parent ions
were activated for 10 ms. Dynamic exclusion was used (60
seconds exclusion window).
If one of the three most abundant fragment ions in the CID
mass spectrum corresponded to a neutral loss of 43 Da (m/z
0.5) from the precursor peptide, saETD of the precursor ion wasThis journal is ª The Royal Society of Chemistry 2011triggered. saETD was performed in the ion trap and detected in
the Orbitrap with a resolution of 7500 at m/z 400. Precursor ions
were isolated in the ion trap with an isolation width of 3 Th.
AGC target value was 2  105 charges, maximum fill time 1000
ms with 2 microscans co-added per mass spectrum. saETD was
performed for 130 ms with a normalised supplemental activation
energy of 25%.Data analysis
Data were analysed by use of the Xcalibur 2.1 software. Data
from the samples containing the singly citrullinated peptides
were searched against the IPI human database (v 3.66, contain-
ing 86 850 sequences) supplemented with the sequences of the
three synthetic peptides added using the SEQUEST51 algorithm
within the Proteome Discoverer 1.0 SP1 software package
(Thermo Scientific, Bremen, Germany). Mono-isotopic
precursor and fragment ions were searched with a mass tolerance
of 5 ppm (precursor) and 0.1 Da (fragment) for CID and 0.02 Da
for saETD. Proteome Discoverer separated the CID and ETD
data prior to searches. For CID data, b and y ions were
considered. For saETD data, c and zc ions were considered. The
carboxyamidomethylation of cysteine was specified as a fixed
modification in the saliva search. Carboxymethylation of
cysteine was specified in the six protein mix search. Phosphory-
lation (serine, threonine and tyrosine), oxidation (methionine),
acetylation (lysine), deamidation (asparagine and glutamine) and
citrullination (arginine) were set as variable modifications in both
searches. In both searches the maximum number of missed
cleavages was 2.
Analysis of the data from the samples containing the doubly
citrullinated peptide was performed using the SEQUEST algo-
rithm within the Proteome Discoverer 1.1 software package. The
data were searched against the IPI human database (v 3.66,
containing 86850 sequences) supplemented with the sequences of
the four synthetic peptides. Search parameters were as above.
The results were filtered using XCorr versus charge state (2+
ions with a score less than 2 were rejected, 3+ ions with scores
<2.25 were rejected and 4+ ions with scores <2.5 were rejected).
XCorr is a measure of how close an experimental MS/MS
spectrum is to the theoretical MS/MS spectrum. Higher scores
equate to greater confidence in a peptide match. XCorr values
were calculated by Proteome Discoverer.Conclusions
Citrullination could be used as a sensitive and specific early
biomarker for several debilitating chronic inflammatory diseases.
We have shown that by exploiting the characteristic CID frag-
mentation of citrulline residues, i.e., loss of isocyanic acid, to
trigger saETD it is possible to perform targeted analysis of cit-
rullinated peptides. The approach results in zero false positives,
and the ambiguity of citrullination vs. deamidation is overcome.
Additionally, the approach removes the requirement to chemi-
cally modify the samples. Three of the four synthetic citrullinated
peptides were identified with high confidence by saETD. For
triply charged ions, saETD identifies the peptides with greater
XCorr scores than the CID of the triply charged ions. In the six
protein mix analysis for the doubly charged ions of the syntheticAnal. Methods, 2011, 3, 259–266 | 265
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View Onlinepeptides, the XCorr values for the CID spectra are higher than
those for the saETD spectra. For the saliva analysis, the saETD
XCorr values of the doubly charged synthetic peptide ions are
equal to or higher than the CID spectra. The CID mass spectrum
of the peptide (VVEXHQSACK) did not result in a positive
identification in the database search for either analysis. This
study shows that, although CID identifies two of the four
peptides, there are multiple false positives identified from CID
spectra, the majority of which are the result of deamidation
rather than deimination. This has implications for the use of CID
as a stand-alone technique for automated analysis of citrulli-
nated proteins as all identified modified peptides would require
manual validation. This work shows that a targeted approach
which exploits the speed and characteristic fragmentation of
citrullinated peptides in CID in order to focus their analysis by
ETD results in highly confident assignments, zero false positives
and zero false negatives.Acknowledgements
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